Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the CPRD

Author
C. Morgan
A. Durand
T. McCormack
E. Hughes
T. Berni
R. Lahoz
Keywords
Humans
Cholesterol, LDL
*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
*Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology
*Cardiovascular Diseases/drug therapy
Retrospective Studies
Cholesterol
*Atherosclerosis/complications/epidemiology
*Stroke/epidemiology/etiology
United Kingdom/epidemiology
Low-density lipoprotein cholesterol
Major adverse cardiovascular events
atherosclerotic cardiovascular disease
lipid-lowering therapy
Type 2 diabetes
Year of Publication
2023
Journal
BMJ Open
Volume
13
Number of Pages
e064541
ISBN Number
2044-6055
Accession Number
38030254
DOI
10.1136/bmjopen-2022-064541